HSPT
Horizon Space Acquisition II Corp. Ordinary shareHSPT
HSPT
About: Horizon Space Acquisition II Corp is a newly organized blank check company.
0
Funds holding %
of 7,327 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
55.52% more ownership
Funds ownership: 0% [Q4 2024] → 55.52% (+55.52%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for HSPT.
Financial journalist opinion
Neutral
Accesswire
2 months ago
Horizon Space Acquisition II Corp. Announces Definitive Business Combination Agreement with SL Bio Ltd.
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Horizon Space Acquisition II Corp. ("HSPT") (Nasdaq:HSPT), a publicly traded special purpose acquisition company, and SL Bio Ltd. ("SL Bio"), a clinical-stage biomedical company specialized in developing groundbreaking cellular and gene therapies for skin care and cancer recovery, today announced that they have entered into a definitive business combination agreement (the "Business Combination Agreement").
Neutral
Accesswire
5 months ago
Horizon Space Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on February 5, 2025
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2025 / Horizon Space Acquisition II Corp. (the "Company") (Nasdaq:HSPT), a blank check company, today announced that, commencing on February 5, 2025, holders of the 5,750,000 units (the "Units") sold in the Company's initial public offering (the "Offering") including Units sold upon a full exercise of the underwriters' over-allotment option, may elect to separately trade the ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market ("NASDAQ") under the symbol "HSPTU.
Charts implemented using Lightweight Charts™